Inactive Instrument
Lotus Pharmaceuticals, Inc. Stock Other OTC
Stocks
LTUS
US5457152032
Pharmaceuticals
OTC Markets Traded| Market Cap | 9.74M 8.38M 7.88M 7.2M 13.47M 919M 13.51M 93.14M 36.14M 472M 36.56M 35.76M 1.52B | P/E 2009 |
3.88x | P/E 2010 | 4.84x |
|---|---|---|---|---|---|
| Enterprise Value | 14.38M 12.38M 11.64M 10.64M 19.9M 1.36B 19.95M 138M 53.39M 697M 54.01M 52.83M 2.24B | EV / Sales 2009 |
1.02x | EV / Sales 2010 | 0.95x |
| Free-Float |
99% | Yield 2009 * |
-
| Yield 2010 | - |
| 1 day | +41.51% |
| Manager | Title | Age | Since |
|---|---|---|---|
Georgene Rivers
CEO | Chief Executive Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Georgene Rivers
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +41.51% | -18.92% | - | - | 7.93M | |
| -0.89% | -1.09% | +20.02% | +71.25% | 48.26B | |
| -1.72% | -1.15% | +47.28% | +115.51% | 40.5B | |
| -2.01% | -5.96% | +10.68% | +80.50% | 11.83B | |
| -0.70% | -2.70% | -12.22% | +11.80% | 11.85B | |
| +0.57% | -0.56% | +26.56% | +154.33% | 9.36B | |
| -1.67% | -0.35% | +41.04% | -12.04% | 7.37B | |
| +0.08% | -4.11% | +22.91% | +43.56% | 7.5B | |
| -0.89% | -3.09% | +22.42% | +220.05% | 7.28B | |
| -0.16% | -2.36% | -42.27% | +15.39% | 5.19B | |
| Average | +3.41% | -2.12% | +15.16% | +77.82% | 16.57B | |
| Weighted average by Cap. | -1.06% | -1.72% | +23.66% | +84.31% |
| 2009 | 2010 | |
|---|---|---|
| Net sales | 57.82M 49.76M 46.82M 42.77M 80M 5.46B 80.22M 553M 215M 2.8B 217M 212M 9.02B | 72.7M 62.56M 58.86M 53.76M 101M 6.86B 101M 695M 270M 3.52B 273M 267M 11.34B |
| Net income | 16.43M 14.14M 13.3M 12.15M 22.73M 1.55B 22.8M 157M 61M 796M 61.7M 60.36M 2.56B | 14.42M 12.41M 11.68M 10.67M 19.96M 1.36B 20.01M 138M 53.55M 699M 54.17M 52.99M 2.25B |
| Net Debt | 5.29 4.56 4.29 3.92 7.32 499.82 7.34 50.65 19.65 256.44 19.88 19.45 826.14 | 4.65 4 3.76 3.44 6.43 438.73 6.45 44.46 17.25 225.1 17.45 17.07 725.16 |
Employees
-
Sector
Pharmaceuticals
